Pacira Pharmaceuticals reported $103.66M in Stock for its first fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Stock Change
Acelrx Pharmaceuticals ACRX:US $ 1.04M 0.07M
Amerisourcebergen ABC:US $ 15514.85M 779.08M
Astellas Pharma 4503:JP Y 153072M 1496M
Bristol Myers Squibb BMY:US $ 2104M 9M
Cara Therapeutics CARA:US 1.91M 677K
Endo International Ordinary Shares ENDP:US $ 283.83M 0.27M
Heron Therapeutics HRTX:US $ 56.47M 8.09M
JAZZ PHA JAZZ:US $ 985.45M 87.27M
Johnson & Johnson JNJ:US $ 10990M 603M
Lannett LCI:US $ 95.43M 10.34M
Nektar Therapeutics NKTR:US $ 15.38M 0.42M
Pacira Pharmaceuticals PCRX:US $ 103.66M 5.11M
Perrigo Ordinary Shares PRGO:US $ 1022.4M 2.2M
Pfizer PFE:US $ 9979M 920M
Revance Therapeutics RVNC:US $ 10.66M 0.5M
Supernus Pharmaceuticals SUPN:US $ 88.8M 2.84M
Teva Pharmaceutical TEVA:IT 4.01B 194M
Xeris Pharmaceuticals Inc XERS:US $ 16.87M 1.25M
Zoetis ZTS:US $ 2057M 134M